AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 282: L1082-L1091, 2002. First published January 4, 2002; doi:10.1152/ajplung.00358.2001
1040-0605/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/5/L1082    most recent
00358.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, A. U.
Right arrow Articles by Fink, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, A. U.
Right arrow Articles by Fink, M. P.
Vol. 282, Issue 5, L1082-L1091, May 2002

Liposomal NAD+ prevents diminished O2 consumption by immunostimulated Caco-2 cells

Abrar U. Khan, Russell L. Delude, Yong Y. Han, Penny L. Sappington, Xianonan Han, Joseph A. Carcillo, and Mitchell P. Fink

Departments of Critical Care Medicine, Pediatrics, and Pathology and Center for Clinical Pharmacology, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania 15261

Accumulating data support the view that sepsis is associated with an acquired intrinsic derangement in the ability of cells to consume O2, a phenomenon that has been termed "cytopathic hypoxia." We sought to use an in vitro "reductionist" model system using cultured cells stimulated with proinflammatory cytokines to test the hypothesis that cytopathic hypoxia is mediated, at least in part, by depletion of intracellular levels of NAD+/NADH secondary to activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP). We measured O2 consumption by Caco-2 enterocytes growing on microcarrier beads after cells were incubated for 24 h under control conditions or with cytomix, a mixture of tumor necrosis factor-alpha , interleukin-1beta , and interferon-gamma . Immunostimulated cells consumed O2 at about one-half the rate of control cells, but this effect was largely prevented if any one of the following pharmacological agents was present during the period of incubation with cytomix: 4,5-dihydroxy-1,3-benzene disulfonic acid, a superoxide radical anion scavenger; 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, a nitric oxide scavenger; 5,10,15,20- tetrakis-[4-sulfonatophenyl]-porphyrinato-iron[III], a peroxynitrite (ONOO-) decomposition catalyst; urate, an ONOO- scavenger; 3-aminobenzamide, a PARP inhibitor; or N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide HCl, a chemically dissimilar and more potent PARP inhibitor. The decrease in O2 uptake induced by cytomix was associated with decreased cellular levels of NAD+/NADH. The decrease in cellular NAD+/NADH content and the decrease in O2 uptake induced by cytomix were completely abrogated if liposome-encapsulated NAD+ was added to the cultures during immunostimulation. Empty liposomes also increased O2 uptake by immunostimulated Caco-2 cells, but much less effectively than liposomes containing NAD+. These data are consistent with the view that enterocytes exposed to proinflammatory cytokines consume less O2 due to NAD+/NADH depletion secondary to activation of PARP by ONOO- or other oxidants.

poly(ADP-ribose) polymerase; nitric oxide; peroxynitrite; enterocyte; epithelium; intestinal


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
T. Luk, Z. Malam, and J. C. Marshall
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
J. Leukoc. Biol., April 1, 2008; 83(4): 804 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Szabo and C. Szabo
Reply to the Editor
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 324 - 325.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Scharte, X. Han, D. J. Bertges, M. P. Fink, and R. L. Delude
Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes
Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G373 - G384.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. S. Hotchkiss and I. E. Karl
The Pathophysiology and Treatment of Sepsis
N. Engl. J. Med., January 9, 2003; 348(2): 138 - 150.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Virag and C. Szabo
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online